Revvity (RVTY) Current Deferred Revenue (2014 - 2016)
Revvity (RVTY) posted Current Deferred Revenue of $163.2 million for Q1 2016, down 3.41% quarter-over-quarter from $168.9 million in Q4 2014, and down 3.41% year-on-year from $168.9 million in Q1 2015.
Revvity (RVTY) Current Deferred Revenue (2014 - 2016) Analysis & Trends
Revvity (RVTY) has reported Current Deferred Revenue for 2 consecutive years, with $163.2 million the latest figure, recorded in Q1 2016.
- Current Deferred Revenue for Q1 2016 came in at $163.2 million, down 3.41% year-over-year; the trailing twelve-month figure through Jan 2016 was $163.2 million (down 3.41% YoY), and the FY2016 annual result was $163.2 million, down 3.41% from the prior year.
- Current Deferred Revenue was $163.2 million for Q1 2016 at Revvity, down from $168.9 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $168.9 million in Q4 2014 and troughed at $163.2 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Revvity | 12.62 Bn | 11.76 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 3, 2016 | 163.17 Mn |
| Dec 28, 2014 | 168.93 Mn |